A phase 1 trial of alisertib and romidepsin for relapsed/refractory aggressive B-cell and T-cell lymphomas

Tekijä Strati, Paolo, Nastoupil, Loretta J., Davis, Richard E, Fayad, Luis E., Fowler, Nathan, Hagemeister, Fredrick B., Kwak, Larry, Oki, Yasuhiro, Wang, Michael, Westin, Jason, Ruben, Charnelle E., Wesson, Emily T., Piekarz, Richard, Fanale, Michelle A., Lee, Hun Ju
Julkaisussa Haematologica (2020)

A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma

Tekijä Strati, Paolo, Chihara, Dai, Oki, Yasuhiro, Fayad, Luis E, Fowler, Nathan, Nastoupil, Loretta, Romaguera, Jorge E, Samaniego, Felipe, Garg, Naveen, Feng, Lei, Wesson, Emily T., Ruben, Charnelle E., Stafford, Mildred D., Nieto, Yago, Khouri, Issa F, Hosing, Chitra, Horowitz, Sandra B., Kamble, Rammurti T-., Fanale, Michelle A.
Julkaisussa Haematologica (2018)